Pommiers, France

Philippe Moingeon

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Philippe Moingeon

Introduction

Philippe Moingeon is a notable inventor based in Pommiers, France. He has made significant contributions to the field of immunology, particularly in the development of immunogenic polypeptides and methods for enhancing immune responses to tumor antigens. With a total of 3 patents, his work has implications for cancer treatment and vaccine development.

Latest Patents

One of Philippe Moingeon's latest patents is titled "Immunogenic polypeptides encoded by MAGE minigenes and uses thereof." This invention discloses immunogenic polypeptides that comprise several MAGE-specific antigen epitopes selected from different members of the MAGE protein family. It includes nucleic acids coding for these polypeptides, recombinant viruses, and cells that contain these nucleic acids, along with various compositions. The patent also outlines methods for eliciting or inducing MAGE-specific immune responses using these immunogenic agents.

Another significant patent is the "Method of inducing and/or enhancing an immune response to tumor antigens." This improved method involves administering a tumor antigen, nucleic acid coding for it, vectors, and/or cells containing the nucleic acid, or vaccines to a lymphatic site to enhance the immune response.

Career Highlights

Philippe Moingeon has worked with prominent organizations in the field of biotechnology and pharmaceuticals. He has been associated with Sanofi Pasteur Inc., a leading global vaccine company, and the Ludwig Institute for Cancer Research Limited, which focuses on cancer research and treatment.

Collaborations

Throughout his career, Philippe has collaborated with esteemed colleagues, including James Tartaglia and Neil L Berinstein. These collaborations have likely contributed to the advancement of his research and innovations in immunology.

Conclusion

Philippe Moingeon's work exemplifies the intersection of innovation and medical science. His patents and career achievements reflect a commitment to advancing cancer treatment through immunological research. His contributions continue to influence the field and hold promise for future developments in immunotherapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…